Breaking News Bar

Business News and Information

The Daily Herald Market Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
EGALET RG (NQ: EGLT)
0.3660 USD  -0.0037 (-1.00%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 672,395
Open 0.3700
Bid (Size) 0.3000 (4500)
Ask (Size) 0.3900 (1200)
Prev. Close 0.3697
Today's Range 0.3395 - 0.3700
52wk Range 0.3395 - 1.589
Shares Outstanding 52,987,321
Dividend Yield N/A
Performance
YTD
-64.47%
-64.47%
1 Month
-19.67%
-19.67%
3 Month
-43.69%
-43.69%
6 Month
-59.78%
-59.78%
1 Year
-74.23%
-74.23%
Top News
More News
Pre-Market Research Reports on Biotech Stocks -- Dermira, Dicerna Pharma, Egalet, and Eidos Therapeutics
If you want a free Stock Review on DERM, DRNA, EGLT, and EIDX sign up now at https://stocktraderreport.com/registration/. On Monday, key US indices were mixed as the NASDAQ Composite finished the... Read More
from PR Newswire
Egalet Appoints Industry Veteran John Varian to Board of Directors
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions,... Read More
from PR Newswire
More News
Read More
Egalet to Participate in Panels at 2018 BIO International Convention and JMP Life Sciences Conference
from PR Newswire
Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray
from PR Newswire
Report: Developing Opportunities within Integer, Sykes Enterprises, Protagonist Therapeutics, Egalet, Watsco, and Extra Space Storage — Future Expectations, Projections Moving into 2018
from GlobeNewswire News Releases
Egalet Reports First Quarter 2018 Financial Results
from PR Newswire
Egalet Announces National Pharmacy Benefit Manager to Cover SPRIX® Nasal Spray and ARYMO® ER
from PR Newswire
Egalet to Present at the 3rd Annual Disruptive Growth & Healthcare Conference
from ACCESSWIRE
Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse
from PR Newswire
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on May 8, 2018
from PR Newswire
Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account